Peptide Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape
The global peptide therapeutics market is expected to grow at a CAGR of around 9.0% during 2023-2030. This report on global peptide therapeutics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global peptide therapeutics market by segmenting the market based on type, manufacturer, synthesis technology, routes of administration, application and region. Also, detailed profiles of companies operating in the peptide therapeutics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
Base Year: 2022
Historical Period: 2018-2022
Forecast Period: 2023-2030
Market by Type
Market Drivers
- Rising Geriatric Population
- Increasing Prevalence of Cancer
- Technological Advancements
- Poor Chemical and Physical Stability
- Presence of Stringent Safety Regulations
Base Year: 2022
Historical Period: 2018-2022
Forecast Period: 2023-2030
Market by Type
- Innovative
- Generic
- Outsourced
- In-house
- Solid Phase Peptide Synthesis
- Liquid Phase Peptide Synthesis
- Hybrid Technology
- Parenteral
- Oral
- Others
- Gastrointestinal Disorders
- Neurological Disorders
- Metabolic Disorders
- Cancer
- Others
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- Turkey
- Iran
- United Arab Emirates
- Rest of Middle East & Africa
1. PREFACE
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. KEY INSIGHTS
3. GLOBAL PEPTIDE THERAPEUTICS MARKET
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. GLOBAL PEPTIDE THERAPEUTICS MARKET ANALYSIS
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. GLOBAL PEPTIDE THERAPEUTICS MARKET BY TYPE
5.1. Introduction
5.2. Innovative
5.3. Generic
6. GLOBAL PEPTIDE THERAPEUTICS MARKET BY TYPE OF MANUFACTURER
6.1. Introduction
6.2. Outsourced
6.3. In-house
7. GLOBAL PEPTIDE THERAPEUTICS MARKET BY SYNTHESIS TECHNOLOGY
7.1. Introduction
7.2. Solid Phase Peptide Synthesis
7.3. Liquid Phase Peptide Synthesis
7.4. Hybrid Technology
8. GLOBAL PEPTIDE THERAPEUTICS MARKET BY ROUTES OF ADMINISTRATION
8.1 Introduction
8.2 Parenteral
8.3 Oral
8.4 Others
9. GLOBAL PEPTIDE THERAPEUTICS MARKET APPLICATION
9.1. Gastrointestinal Disorders
9.2. Neurological Disorders
9.3. Metabolic Disorders
9.4. Cancer
9.5. Others
10. GLOBAL PEPTIDE THERAPEUTICS MARKET BY REGION
10.1 Introduction
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Netherlands
10.2.8 Rest of the Europe
10.3 North America
10.3.1 United States
10.3.2 Canada
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Indonesia
10.4.7 Rest of the Asia Pacific
10.5 Latin America
10.5.1 Mexico
10.5.2 Brazil
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 Turkey
10.6.3 Iran
10.6.4 United Arab Emirates
10.6.5 Rest of Middle East & Africa
11. SWOT ANALYSIS
12. PORTER’S FIVE FORCES
13. MARKET VALUE CHAIN ANALYSIS
14. COMPETITIVE LANDSCAPE
14.1. Competitive Scenario
14.2. Company Profiles
14.2.1. Amgen Inc.
14.2.2. Apitope International NV
14.2.3. Arch Biopartners Inc.
14.2.4. AstraZeneca plc
14.2.5. Circle Pharma Inc.
14.2.6. Corden Pharma GmbH
14.2.7. F. Hoffmann-La Roche AG
14.2.8. Ipsen Group
14.2.9. Lonza Group AG
14.2.10. Novo Nordisk A/S
14.2.11. Pfizer Inc.
14.2.12. Teva Pharmaceuticals Industries Ltd.
14.2.13. Zealand Pharma A/S.
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. KEY INSIGHTS
3. GLOBAL PEPTIDE THERAPEUTICS MARKET
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. GLOBAL PEPTIDE THERAPEUTICS MARKET ANALYSIS
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. GLOBAL PEPTIDE THERAPEUTICS MARKET BY TYPE
5.1. Introduction
5.2. Innovative
5.3. Generic
6. GLOBAL PEPTIDE THERAPEUTICS MARKET BY TYPE OF MANUFACTURER
6.1. Introduction
6.2. Outsourced
6.3. In-house
7. GLOBAL PEPTIDE THERAPEUTICS MARKET BY SYNTHESIS TECHNOLOGY
7.1. Introduction
7.2. Solid Phase Peptide Synthesis
7.3. Liquid Phase Peptide Synthesis
7.4. Hybrid Technology
8. GLOBAL PEPTIDE THERAPEUTICS MARKET BY ROUTES OF ADMINISTRATION
8.1 Introduction
8.2 Parenteral
8.3 Oral
8.4 Others
9. GLOBAL PEPTIDE THERAPEUTICS MARKET APPLICATION
9.1. Gastrointestinal Disorders
9.2. Neurological Disorders
9.3. Metabolic Disorders
9.4. Cancer
9.5. Others
10. GLOBAL PEPTIDE THERAPEUTICS MARKET BY REGION
10.1 Introduction
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Netherlands
10.2.8 Rest of the Europe
10.3 North America
10.3.1 United States
10.3.2 Canada
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Indonesia
10.4.7 Rest of the Asia Pacific
10.5 Latin America
10.5.1 Mexico
10.5.2 Brazil
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 Turkey
10.6.3 Iran
10.6.4 United Arab Emirates
10.6.5 Rest of Middle East & Africa
11. SWOT ANALYSIS
12. PORTER’S FIVE FORCES
13. MARKET VALUE CHAIN ANALYSIS
14. COMPETITIVE LANDSCAPE
14.1. Competitive Scenario
14.2. Company Profiles
14.2.1. Amgen Inc.
14.2.2. Apitope International NV
14.2.3. Arch Biopartners Inc.
14.2.4. AstraZeneca plc
14.2.5. Circle Pharma Inc.
14.2.6. Corden Pharma GmbH
14.2.7. F. Hoffmann-La Roche AG
14.2.8. Ipsen Group
14.2.9. Lonza Group AG
14.2.10. Novo Nordisk A/S
14.2.11. Pfizer Inc.
14.2.12. Teva Pharmaceuticals Industries Ltd.
14.2.13. Zealand Pharma A/S.
LIST OF TABLES
Table 1: Global Peptide Therapeutics Market Portraiture
Table 2: Global Peptide Therapeutics Market by Type (in US$ Million), 2022 & 2030
Table 3: Global Peptide Therapeutics Market by Manufacturer (in US$ Million), 2022 & 2030
Table 4: Global Peptide Therapeutics Market by Synthesis Technology (in US$ Million), 2022 & 2030
Table 5: Global Peptide Therapeutics Market by Routes of Administration (in US$ Million), 2022 & 2030
Table 6: Global Peptide Therapeutics Market by Application (in US$ Million), 2022 & 2030
Table 7: Global Peptide Therapeutics Market by Region (in US$ Million), 2022 & 2030
Table 8: Europe Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 9: North America Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 10: Asia Pacific Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 11: Latin America Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 12: Middle East & Africa Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 13: List of Key Players
Table 1: Global Peptide Therapeutics Market Portraiture
Table 2: Global Peptide Therapeutics Market by Type (in US$ Million), 2022 & 2030
Table 3: Global Peptide Therapeutics Market by Manufacturer (in US$ Million), 2022 & 2030
Table 4: Global Peptide Therapeutics Market by Synthesis Technology (in US$ Million), 2022 & 2030
Table 5: Global Peptide Therapeutics Market by Routes of Administration (in US$ Million), 2022 & 2030
Table 6: Global Peptide Therapeutics Market by Application (in US$ Million), 2022 & 2030
Table 7: Global Peptide Therapeutics Market by Region (in US$ Million), 2022 & 2030
Table 8: Europe Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 9: North America Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 10: Asia Pacific Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 11: Latin America Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 12: Middle East & Africa Peptide Therapeutics Market by Country (in US$ Million), 2022 & 2030
Table 13: List of Key Players
LIST OF FIGURES
Figure 1: Global Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 2: Global Peptide Therapeutics Market by Type, 2022
Figure 3: Global Peptide Therapeutics Market by Manufacturer, 2022
Figure 4: Global Peptide Therapeutics Market by Synthesis Technology, 2022
Figure 5: Global Peptide Therapeutics Market by Routes of Administration, 2022
Figure 6: Global Peptide Therapeutics Market by Application, 2022
Figure 7: Global Peptide Therapeutics Market by Region, 2022
Figure 8: Global Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 9: Global Peptide Therapeutics Market by Type (in %), 2022 & 2030
Figure 10: Global Innovative Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 11: Global Innovative Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 12: Global Generic Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 13: Global Generic Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 14: Global Peptide Therapeutics Market by Manufacturer (in %), 2022 & 2030
Figure 15: Global Outsourced Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 16: Global Outsourced Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 17: Global In-house Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 18: Global In-house Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 19: Global Peptide Therapeutics Market by Synthesis Technology (in %), 2022 & 2030
Figure 20: Global Solid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 21: Global Solid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 22: Global Liquid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 23: Global Liquid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 24: Global Hybrid Technology Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 25: Global Hybrid Technology Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 26: Global Peptide Therapeutics Market by Routes of Administration (in %), 2022 & 2030
Figure 27: Global Parenteral Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 28: Global Parenteral Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 29: Global Oral Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 30: Global Oral Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 31: Global Other Routes of Administration Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 32: Global Other Routes of Administration Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 33: Global Peptide Therapeutics Market by Routes of Application (in %), 2022 & 2030
Figure 34: Global Gastrointestinal Disorders Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 35: Global Gastrointestinal Disorders Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 36: Global Neurological Disorders Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 37: Global Neurological Disorders Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 38: Global Metabolic Disorders Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 39: Global Metabolic Disorders Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 40: Global Cancer Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 41: Global Cancer Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 42: Global Other Applications Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 43: Global Other Applications Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 44: Global Peptide Therapeutics Market by Region (in %), 2022 & 2030
Figure 45: Europe Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 46: Europe Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 47: Europe Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 48: Germany Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 49: United Kingdom Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 50: France Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 51: Italy Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 52: Spain Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 53: Russia Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 54: Netherlands Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 55: North America Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 56: North America Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 57: North America Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 58: United States Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 59: Canada Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 60: Asia Pacific Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 61: Asia Pacific Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 62: Asia Pacific Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 63: China Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 64: Japan Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 65: India Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 66: South Korea Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 67: Australia Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 68: Indonesia Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 69: Latin America Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 70: Latin America Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 71: Latin America Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 72: Mexico Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 73: Brazil Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 74: Argentina Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 75: Middle East & Africa Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 76: Middle East & Africa Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 77: Middle East & Africa Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 78: Saudi Arabia Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 79: Turkey Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 80: Iran Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 81: UAE Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 82: Market Value Chain
Figure 1: Global Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 2: Global Peptide Therapeutics Market by Type, 2022
Figure 3: Global Peptide Therapeutics Market by Manufacturer, 2022
Figure 4: Global Peptide Therapeutics Market by Synthesis Technology, 2022
Figure 5: Global Peptide Therapeutics Market by Routes of Administration, 2022
Figure 6: Global Peptide Therapeutics Market by Application, 2022
Figure 7: Global Peptide Therapeutics Market by Region, 2022
Figure 8: Global Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 9: Global Peptide Therapeutics Market by Type (in %), 2022 & 2030
Figure 10: Global Innovative Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 11: Global Innovative Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 12: Global Generic Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 13: Global Generic Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 14: Global Peptide Therapeutics Market by Manufacturer (in %), 2022 & 2030
Figure 15: Global Outsourced Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 16: Global Outsourced Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 17: Global In-house Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 18: Global In-house Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 19: Global Peptide Therapeutics Market by Synthesis Technology (in %), 2022 & 2030
Figure 20: Global Solid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 21: Global Solid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 22: Global Liquid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 23: Global Liquid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 24: Global Hybrid Technology Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 25: Global Hybrid Technology Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 26: Global Peptide Therapeutics Market by Routes of Administration (in %), 2022 & 2030
Figure 27: Global Parenteral Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 28: Global Parenteral Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 29: Global Oral Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 30: Global Oral Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 31: Global Other Routes of Administration Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 32: Global Other Routes of Administration Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 33: Global Peptide Therapeutics Market by Routes of Application (in %), 2022 & 2030
Figure 34: Global Gastrointestinal Disorders Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 35: Global Gastrointestinal Disorders Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 36: Global Neurological Disorders Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 37: Global Neurological Disorders Peptide Therapeutics Market(in US$ Million), 2023-2030
Figure 38: Global Metabolic Disorders Peptide Therapeutics Market(in US$ Million), 2018-2022
Figure 39: Global Metabolic Disorders Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 40: Global Cancer Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 41: Global Cancer Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 42: Global Other Applications Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 43: Global Other Applications Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 44: Global Peptide Therapeutics Market by Region (in %), 2022 & 2030
Figure 45: Europe Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 46: Europe Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 47: Europe Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 48: Germany Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 49: United Kingdom Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 50: France Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 51: Italy Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 52: Spain Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 53: Russia Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 54: Netherlands Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 55: North America Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 56: North America Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 57: North America Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 58: United States Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 59: Canada Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 60: Asia Pacific Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 61: Asia Pacific Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 62: Asia Pacific Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 63: China Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 64: Japan Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 65: India Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 66: South Korea Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 67: Australia Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 68: Indonesia Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 69: Latin America Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 70: Latin America Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 71: Latin America Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 72: Mexico Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 73: Brazil Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 74: Argentina Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 75: Middle East & Africa Peptide Therapeutics Market (in US$ Million), 2018-2022
Figure 76: Middle East & Africa Peptide Therapeutics Market (in US$ Million), 2023-2030
Figure 77: Middle East & Africa Peptide Therapeutics Market by Country (in %), 2022 & 2030
Figure 78: Saudi Arabia Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 79: Turkey Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 80: Iran Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 81: UAE Peptide Therapeutics Market (in US$ Million), 2018-2030
Figure 82: Market Value Chain
